Clinical Study
Expressions of CXCL12/CXCR4 in Oral Premalignant and Malignant Lesions
Table 1
Association of CXCL12 and CXCR4 expressions in OLK and OSCC tissues.
| Histopathology | Total cases (%) | CXCL12-positive cases (%) | CXCL12-negative cases (%) | P
*
|
| OLK | 24 | 12 (50%) | 12 (50%) | 0.003 | CXCR4-positive cases (%) | 9 (37.5%) | 8 (33.3%) | 1 (4.2%) | CXCR4-negative cases (%) | 15 (62.5%) | 4 (16.7%) | 11 (45.8%) | OSCC | 40 | 25 (62.5%) | 15 (37.5%) | 0.001 | CXCR4-positive cases (%) | 24 (60.0%) | 20 (50.0%) | 4 (10.0%) | CXCR4-negative cases (%) | 16 (40.0%) | 5 (12.5%) | 11 (27.5%) |
|
|
*Chi-square test, relationship between CXCL12 and CXCR4 expressions.
|